Literature DB >> 2112350

The effects of exposure time, drug concentration, and temperature on the activity of ethambutol versus Mycobacterium tuberculosis.

P R Gangadharam1, P F Pratt, V K Perumal, M D Iseman.   

Abstract

In a series of dynamic in vitro studies designed to assess the activity of ethambutol (EMB) against Mycobacterium tuberculosis, we made the following observations. Ethambutol showed bactericidal action with 10 micrograms/ml concentration when in constant contact with M. tuberculosis. At a lower concentration, bactericidal action was evident up to 6 days; after that time, this effect was lost owing to the development of drug-resistant mutants. The bactericidal action of ethambutol in this model was similar to that of rifampin and isoniazid. Pulsed exposure for 96 h caused a four-log reduction in cfu counts, but the growth resumed rapidly. The bactericidal action of ethambutol was maximal at 37 degrees C and less at low temperatures. Ethambutol showed little activity against cultures growing at 8 degrees C continuously that were incubated for only 1 h at 37 degrees C. Against cultures growing at 8 degrees C that were brought to 37 degrees C for 6 h, its action was similar to that of rifampin. Ethambutol combined with other drugs showed bactericidal action, although the activity was less than that of the combination isoniazid-streptomycin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112350     DOI: 10.1164/ajrccm/141.6.1478

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  6 in total

Review 1.  Dormancy of Mycobacterium tuberculosis and latency of disease.

Authors:  L G Wayne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

2.  Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods.

Authors:  B Madison; B Robinson-Dunn; I George; W Gross; H Lipman; B Metchock; A Sloutsky; G Washabaugh; G Mazurek; J Ridderhof
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

3.  Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.

Authors:  I J Eltringham; S M Wilson; F A Drobniewski
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

4.  Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.

Authors:  Linda M Parsons; Max Salfinger; Anne Clobridge; Jillian Dormandy; Lisa Mirabello; Valerie L Polletta; Ahmet Sanic; Oleg Sinyavskiy; Susan C Larsen; Jeffrey Driscoll; Genet Zickas; Harry W Taber
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 5.  Drug treatment of tuberculosis--1992.

Authors:  P T Davidson; H Q Le
Journal:  Drugs       Date:  1992-05       Impact factor: 9.546

6.  Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.

Authors:  Angela M Starks; Aysel Gumusboga; Bonnie B Plikaytis; Thomas M Shinnick; James E Posey
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.